[1] Bade B C, Dela Cruz C S. Lung cancer 2020:Epidemiology, etiology, and prevention[J]. Clinics in Chest Medicine, 2020, 41(1):1-24. [2] Nasim F, Sabath B F, Eapen G A. Lung cancer[J]. The Medical Clinics of North America, 2019, 103(3):463-473. [3] Jonna S, Subramaniam D S. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC):An update[J]. Discovery Medicine, 2019, 27(148):167-170. [4] Duma N, Santana-Davila R, Molina J R. Non-small cell lung cancer:Epidemiology, screening, diagnosis, and treat-ment[J]. Mayo Clinic Proceedings, 2019, 94(8):1623-1640. [5] Hung J J, Jeng W J, Chou T Y, et al. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma[J]. Annals of Surgery, 2013, 258(6):1079-1086. [6] Ngam P I, Ong C C, Chai P, et al. Computed tomography coronary angiography-past, present and future[J]. Singapore Medical Journal, 2020, 61(3):109-115. [7] Leiva-Salinas C, Jiang B, Wintermark M. Computed tomography, computed tomography angiography, and perfusion computed tomography evaluation of acute ischemic stroke[J]. Neuroimaging Clinics of North America, 2018, 28(4):565-572. [8] Lee H, Lee S, Cha J G, et al. Postmortem computed tomography and computed tomography angiography:Cardiothoracic imaging applications in forensic medicine[J]. Journal of Thoracic Imaging, 2019, 34(5):286-298. [9] Wu G Y, Woodruff H C, Shen J, et al. Diagnosis of invasive lung adenocarcinoma based on chest ct radiomic features of part-solid pulmonary nodules:A multicenter study[J]. Radiology, 2020, 297(2):451-458. [10] Yanagawa M, Tsubamoto M, Satoh Y, et al. Lung adenocarcinoma at CT with 0.25-mm section thickness and a 2048 matrix:High-spatial-resolution imaging for predicting invasiveness[J]. Radiology, 2020, 297(2):462-471. [11] Sun Y L, Li C, Jin L, et al. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules:Invasive prediction[J]. European Radiology, 2020, 30(7):3650-3659. [12] Shen H B. Low-dose CT for lung cancer screening:Opportunities and challenges[J]. Frontiers of Medicine, 2018, 12(1):116-121. [13] 郝俊丽, 赵明芳. 磨玻璃型肺癌诊治研究进展[J]. 现代肿瘤医学, 2019, 27(12):2203-2206. [14] Holbrook M D, Clark D P, Badea C T. Dual source hybrid spectral micro-CT using an energy-integrating and a photon-counting detector[J]. Physics in Medicine and Biology, 2020, 65(20):205012. [15] Yasukawa M, Ohbayashi C, Kawaguchi T, et al. Analysis of histological grade in resected lung-invasive adenocarcino-ma[J]. Anticancer Research, 2019, 39(3):1491-1500. [16] Li W, Li X Q, Li X P, et al. Lamin B1 overexpresses in lung adenocarcinoma and promotes proliferation in lung cancer cells via AKT pathway[J]. Onco Targets and Therapy, 2020, 13:3129-3139. [17] 伍翠云, 程涛. 周围型肺腺癌CT征象与病理组织分化的相关性[J]. 中国医学计算机成像杂志, 2014, 20(1):33-36. [18] 单士超, 郭春峰. 肺部磨玻璃结节的CT影像特征评估肺腺癌浸润性的价值[J]. 临床研究, 2020, 28(9):10-11. [19] 卫一宾, 马敬伟. CT用于磨玻璃结节样多灶性肺腺癌(MLA)诊断中的价值研究[J]. 影像研究与医学应用, 2019, 3(15):97-98. [20] 于正伦, 张曙光, 许顺. 148例肺腺癌患者的预后影响因素分析[J]. 中国医科大学学报, 2019, 48(11):1045-1048. [21] 张佩佩, 赵君慧. 女性肺癌的临床特征及治疗策略[J]. 现代肿瘤医学, 2020, 28(7):1217-1221. |